Asthma, lung function and allergy in 12-year-old children with very low birth weight: a prospective study

Xiao-Mei Mai1, Per-Olof Gäddlin, Lennart Nilsson

  • 1Department of Molecular and Clinical Medicine, Division of Paediatrics, Linköping University, Linköping, Sweden. xiama@imk.liu.se

Insights

Children born with very low birth weight (VLBW) have increased asthma risk by age 12. Neonatal oxygen supplementation is a key risk factor, while VLBW itself doesn

Area of Science:

  • Pediatric Pulmonology
  • Neonatology
  • Allergy and Immunology

Background:

  • Very low birth weight (VLBW) infants face potential long-term respiratory and allergic health challenges.
  • Understanding the impact of neonatal interventions on later respiratory health in VLBW survivors is crucial.

Purpose of the Study:

  • To investigate the association between very low birth weight (VLBW) and the development of asthma, lung function, and atopy up to 12 years of age.
  • To identify specific neonatal factors contributing to respiratory issues in VLBW children.

Main Methods:

  • Prospective follow-up of 74 VLBW children and 64 matched term-born children for 12 years.
  • Assessment included questionnaires on respiratory and allergic symptoms, spirometry, skin prick tests, and hypertonic saline provocation tests at age 12.
  • Cytokine secretion analysis was performed on stimulated blood leukocyte cultures in a subset of participants.

Main Results:

  • Asthma history was more frequent in VLBW children (22%) compared to term children (9%) by age 12.
  • Neonatal mechanical ventilation and oxygen supplementation were significantly associated with asthma history in univariate analyses.
  • Neonatal oxygen supplementation for >= 9 days was the sole significant predictor in multivariate analysis (adjusted OR 6.7).
  • VLBW children requiring mechanical ventilation showed higher rates of bronchial hyperresponsiveness (60% vs. 28%).
  • Lung function (spirometry) and atopy markers (skin prick tests, allergic symptoms) did not differ significantly between groups.
  • Cytokine levels (IL-4, IL-5, IFN-gamma) were similar between VLBW and term children.

Conclusions:

  • A history of asthma is twice as common in VLBW children by age 12, with neonatal oxygen supplementation being a significant risk factor.
  • Neonatal mechanical ventilation is linked to bronchial hyperresponsiveness at age 12.
  • Very low birth weight itself does not appear to be directly associated with atopy or impaired lung function at 12 years.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma